{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:59:25Z","timestamp":1780646365929,"version":"3.54.1"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00846","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T04:45:10Z","timestamp":1591937110000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation"],"prefix":"10.3389","volume":"11","author":[{"given":"Jacob","family":"Golenser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeen","family":"Salaymeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd Alroof","family":"Higazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahran","family":"Daif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Dzikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J.","family":"Domb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1602\/neurorx.2.4.554","article-title":"Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery","volume":"2","author":"Alavijeh","year":"2005","journal-title":"NeuroRX"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","article-title":"Malaria","volume":"391","author":"Ashley","year":"2018","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ijpharm.2013.05.017","article-title":"Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis","volume":"454","author":"Beloqui","year":"2013","journal-title":"Int. J. Pharm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.neurol.2019.07.008","article-title":"Human cerebral malaria: 2019 mini review","volume":"175","author":"Bruneel","year":"2019","journal-title":"Rev. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S611","DOI":"10.1080\/21691401.2018.1505739","article-title":"Progress in nano-drug delivery of artemisinin and its derivatives: towards to use in immunomodulatory approaches","volume":"46","author":"Charlie-Silva","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nri.2017.138","article-title":"Tissue-specific immunopathology during malaria infection","volume":"18","author":"Coban","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1002401","DOI":"10.1371\/journal.ppat.1002401","article-title":"The role of animal models for research on severe malaria","volume":"8","author":"Craig","year":"2012","journal-title":"PloS Pathog."},{"key":"B8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.mib.2018.09.003","article-title":"Rodent malaria models: insights into human disease and parasite biology","volume":"46","author":"De Niz","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/srep12671","article-title":"Simultaneously targeting inflammatory response and parasite sequestration in brain to treat experimental cerebral malaria","volume":"5","author":"Dende","year":"2015","journal-title":"Sci. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"10062","DOI":"10.1038\/s41598-017-10672-9","article-title":"Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria","author":"Dende","year":"2017","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/1062936X.2019.1665844","article-title":"Toxicity Profiling and prioritization of plant-derived antimalarial agents","volume":"30","author":"Devillers","year":"2019","journal-title":"Environ. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/nmj.NMJ_152_18","article-title":"Investigating the comparative effects of six artemisinin-based combination therapies on plasmodium-induced hepatorenal toxicity","volume":"60","author":"Edagha","year":"2019","journal-title":"Nig. Med. J."},{"key":"B13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/3-540-29967-X_4","article-title":"Experimental models of cerebral malaria","volume-title":"Immunology and immunopathogenesis of malaria.","author":"Engwerda","year":"2005"},{"key":"B14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1875-5364(19)30038-X","article-title":"A brief history of artemisinin: modes of action and mechanism of resistance","volume":"17","author":"Feng","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02016","article-title":"Cerebral malaria in mouse and man","volume":"9","author":"Ghazanfari","year":"2018","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijpddr.2017.05.002","article-title":"Elimination of schistosoma mansoni in infected mice by slow release of artemisone","volume":"7","author":"Gold","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ijpara.2006.02.009","article-title":"Conventional and experimental treatment of cerebral malaria","volume":"36","author":"Golenser","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13071-017-2018-7","article-title":"Controlled release of artemisone for the treatment of experimental cerebral malaria","volume":"10","author":"Golenser","year":"2017","journal-title":"Parasitol. Vectors"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1128\/AAC.01553-13","article-title":"Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: Antiplasmodial effects and immune responses","volume":"58","author":"Guiguemde","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/anie.200352343","article-title":"Stable polyanhydride synthesized from sebacic acid and ricinoleic acid","volume":"257","author":"Haim-Zada","year":"2017","journal-title":"J. Control. Release"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1128\/AAC.47.3.1175.2003","article-title":"Artemisinin antimalarials do not inhibit hemozoin formation","volume":"47","author":"Haynes","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/anie.200503071","article-title":"Artemisone - a highly active antimalarial drug of the artemisinin class","volume":"45","author":"Haynes","year":"2006","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"B23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: Pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.pt.2010.03.006","article-title":"Murine cerebral malaria: the whole story","volume":"26","author":"Hunt","year":"2010","journal-title":"Trends Parasitol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1203\/PDR.0b013e3181eee738","article-title":"Cerebral malaria: Mechanisms of brain injury and strategies for improved neurocognitive outcome","volume":"68","author":"Idro","year":"2010","journal-title":"Pediatr. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.bmcl.2015.03.027","article-title":"Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani","volume":"25","author":"Keurulainen","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nnano.2016.135","article-title":"Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles","volume":"11","author":"Kishimoto","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1097\/01.CCM.0000079603.82822.69","article-title":"Severe falciparum malaria: An important cause of multiple organ failure in Indian intensive care unit patients","volume":"31","author":"Krishnan","year":"2003","journal-title":"Crit. Care Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3109\/10717544.2014.920431","article-title":"Nasal-nanotechnology: revolution for efficient therapeutics delivery","volume":"23","author":"Kumar","year":"2016","journal-title":"Drug Deliv."},{"key":"B30","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ejmech.2018.12.007","article-title":"Current scenario of artemisinin and its analogues for antimalarial activity","volume":"163","author":"Kumari","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2471\/blt.08.060327","article-title":"Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review","volume":"87","author":"Kyu","year":"2009","journal-title":"Bull. World Health Organ."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01444","article-title":"Sticking for a cause: The falciparum malaria parasites cytoadherence paradigm","volume":"10","author":"Lee","year":"2019","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.3892\/mmr.2018.8666","article-title":"Artesunate suppresses oxidative and inflammatory processes by activating Nrf2 and ROS dependent p38 MAPK and protects against cerebral ischemia reperfusion injury","volume":"17","author":"Lu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.pt.2017.03.002","article-title":"Malaria eradication and the hidden parasite reservoir","volume":"33","author":"Markus","year":"2017","journal-title":"Trends Parasitol."},{"key":"B35","unstructured":"Protocol Guide: XTT Assay for Cell Viability and Proliferation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12936-018-2430-2","article-title":"Blood\u2013brain barrier in cerebral malaria: Pathogenesis and therapeutic intervention","volume":"35","author":"Nishanth","year":"2019","journal-title":"Trends Parasitol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4269\/ajtmh.2000.62.409","article-title":"Studies of the neurotoxicity of oral artemisinin derivatives in mice","volume":"62","author":"Nontprasert","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e00288","DOI":"10.1128\/AAC.00288-18","article-title":"The artemisinin derivative artemisone is a potent inhibitor of human cytomegalovirus replication","volume":"62","author":"Oiknine-Djian","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1471-4922(00)01838-9","article-title":"Possible modes of action of the artemisinin-type compounds","volume":"17","author":"Olliaro","year":"2001","journal-title":"Trends Parasitol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ijch.201000027","article-title":"Pasty polymers in cancer drug therapy","volume":"50","author":"Pawar","year":"2010","journal-title":"Isr. J. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/MOP.0000000000000823","article-title":"Outcomes measures in children after acute central nervous system infections and malaria","volume":"31","author":"Postels","year":"2019","journal-title":"Curr. Opin. Pediatr."},{"key":"B42","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4269\/ajtmh.2006.75.637","article-title":"In vitro activity of artemisone compared with artesunate against plasmodium falciparum","volume":"75","author":"Ramharter","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4049\/jimmunol.1900829","article-title":"Desperately seeking therapies for cerebral malaria","volume":"204","author":"Riggle","year":"2020","journal-title":"J. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.phrs.2016.02.017","article-title":"Antischistosomal activity of artemisinin derivatives in vivo and in patients","volume":"110","author":"Saeed","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02554","article-title":"The liver-stage Plasmodium infection is a critical checkpoint for development of experimental cerebral malaria","volume":"10","author":"Sato","year":"2019","journal-title":"Front. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/bdrb.20192","article-title":"Developmental and reproductive toxicity studies on artemisone","volume":"86","author":"Schmuck","year":"2009","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/0897190018782367","article-title":"Severe plasmodium falciparum malaria treated with investigational artesunate in the United States","volume":"33","author":"Shah","year":"2020","journal-title":"J. Pharm. Pract."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/med.21657","article-title":"Artemisinin-derived antimalarial endoperoxides from bench-side to bed-side: Chronological advancements and future challenges","volume":"2020","author":"Tiwari","year":"2020","journal-title":"Med. Res. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1007786","DOI":"10.1371\/journal.ppat.1007786","article-title":"Blood brain barrier disruption in cerebral malaria: Beyond endothelial cell activation","volume":"15","author":"Tunon-Ortiz","year":"2019","journal-title":"PloS Pathog."},{"key":"B50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/026119291003800309","article-title":"Validating animal models for preclinical research: A scientific and ethical discussion","volume":"38","author":"Varga","year":"2010","journal-title":"Altern. Lab. Anim."},{"key":"B51","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1475-2875-13-106","article-title":"Liver changes in severe plasmodium falciparum malaria: histopathology, apoptosis and nuclear factor kappa B expression","volume":"13","author":"Viriyavejakul","year":"2014","journal-title":"Malar. J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/1475-2875-9-227","article-title":"Artemisone effective against murine cerebral malaria","volume":"9","author":"Waknine-Grinberg","year":"2010","journal-title":"Malar. J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e72722","DOI":"10.1371\/journal.pone.0072722","article-title":"Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria","volume":"8","author":"Waknine-Grinberg","year":"2013","journal-title":"PloS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijpara.2016.08.002","article-title":"Severe malaria: what\u2019s new on the pathogenesis front","volume":"47","author":"Wassmer","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0140-6736(19)31097-9","article-title":"Mapping the global prevalence, incidence, and mortality of plasmodium falciparum 2000\u201317: A spatial and temporal modelling study","volume":"394","author":"Weiss","year":"2019","journal-title":"Lancet"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2019.00901","article-title":"Optimal 10-aminoartemisinins with potent transmission-blocking capabilities for new artemisinin combination therapies\u2013activities against blood stage P. falciparum including PfKI3 C580Y mutants and liver stage P. berghei parasites","volume":"7","author":"Wong","year":"2020","journal-title":"Front. Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2125.2011.03925.x","article-title":"Understanding the time course of pharmacological effect: a PKPD approach","volume":"71","author":"Wright","year":"2011","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00846\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T04:45:14Z","timestamp":1591937114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00846\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":57,"alternative-id":["10.3389\/fphar.2020.00846"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00846","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"article-number":"846"}}